Cooper Companies Inc (COO) Shares Sold by Bank of New York Mellon Corp

Bank of New York Mellon Corp reduced its stake in shares of Cooper Companies Inc (NYSE:COO) by 3.0% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 401,659 shares of the medical device company’s stock after selling 12,495 shares during the period. Bank of New York Mellon Corp owned 0.82% of Cooper Companies worth $94,570,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the company. Sumitomo Life Insurance Co. grew its holdings in shares of Cooper Companies by 4.2% during the 2nd quarter. Sumitomo Life Insurance Co. now owns 5,143 shares of the medical device company’s stock valued at $1,211,000 after acquiring an additional 206 shares in the last quarter. Bronfman E.L. Rothschild L.P. grew its holdings in shares of Cooper Companies by 6.8% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 3,622 shares of the medical device company’s stock valued at $853,000 after acquiring an additional 232 shares in the last quarter. Nomura Asset Management Co. Ltd. grew its holdings in shares of Cooper Companies by 1.3% during the 2nd quarter. Nomura Asset Management Co. Ltd. now owns 19,770 shares of the medical device company’s stock valued at $4,655,000 after acquiring an additional 262 shares in the last quarter. Intrust Bank NA grew its holdings in shares of Cooper Companies by 9.0% during the 2nd quarter. Intrust Bank NA now owns 3,209 shares of the medical device company’s stock valued at $756,000 after acquiring an additional 265 shares in the last quarter. Finally, Washington Capital Management Inc. grew its holdings in shares of Cooper Companies by 16.2% during the 2nd quarter. Washington Capital Management Inc. now owns 2,150 shares of the medical device company’s stock valued at $506,000 after acquiring an additional 300 shares in the last quarter. Institutional investors and hedge funds own 97.07% of the company’s stock.

COO has been the topic of several research analyst reports. Zacks Investment Research upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating and set a $288.00 price target on the stock in a report on Wednesday, August 8th. BMO Capital Markets boosted their price target on shares of Cooper Companies from $280.00 to $285.00 and gave the company an “outperform” rating in a report on Friday, August 31st. Oppenheimer set a $270.00 price target on shares of Cooper Companies and gave the company a “hold” rating in a report on Friday, August 31st. Raymond James lifted their price objective on shares of Cooper Companies from $270.00 to $300.00 and gave the company an “outperform” rating in a research note on Friday, September 21st. Finally, ValuEngine raised shares of Cooper Companies from a “hold” rating to a “buy” rating in a research note on Thursday, September 27th. Five analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Cooper Companies presently has a consensus rating of “Buy” and an average price target of $274.25.

COO stock opened at $267.80 on Friday. The company has a debt-to-equity ratio of 0.70, a current ratio of 2.58 and a quick ratio of 1.54. Cooper Companies Inc has a 1 year low of $216.47 and a 1 year high of $280.10. The firm has a market capitalization of $12.76 billion, a P/E ratio of 27.61, a price-to-earnings-growth ratio of 1.97 and a beta of 0.75.

Cooper Companies (NYSE:COO) last released its quarterly earnings data on Thursday, August 30th. The medical device company reported $3.00 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.07 by ($0.07). Cooper Companies had a net margin of 5.23% and a return on equity of 17.53%. The business had revenue of $660.00 million during the quarter, compared to analyst estimates of $653.44 million. Equities analysts forecast that Cooper Companies Inc will post 11.62 earnings per share for the current year.

In other Cooper Companies news, Director Robert S. Weiss sold 58,543 shares of the business’s stock in a transaction on Wednesday, September 5th. The shares were sold at an average price of $252.82, for a total transaction of $14,800,841.26. Following the completion of the transaction, the director now owns 157,710 shares of the company’s stock, valued at approximately $39,872,242.20. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director A Thomas Bender sold 7,150 shares of the business’s stock in a transaction on Monday, September 24th. The stock was sold at an average price of $269.36, for a total transaction of $1,925,924.00. Following the transaction, the director now directly owns 18,355 shares of the company’s stock, valued at approximately $4,944,102.80. The disclosure for this sale can be found here. In the last ninety days, insiders sold 80,809 shares of company stock valued at $20,740,667. 1.60% of the stock is owned by company insiders.

TRADEMARK VIOLATION WARNING: This piece was posted by American Banking News and is the property of of American Banking News. If you are accessing this piece on another publication, it was illegally copied and republished in violation of United States & international copyright and trademark law. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2018/11/10/cooper-companies-inc-coo-shares-sold-by-bank-of-new-york-mellon-corp.html.

About Cooper Companies

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Recommended Story: Rule of 72

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply